my view is this. the fact that the DMC has confirmed continuation of the trial, can only mean that results are positive. Why because if they weren't patient would be required to revert back to conventional therapies, we are talking about life and death here. and I would assume improvements would need to be substantial, minimal deviation would not cut it.
- Forums
- Charts
- here's a thought
MSB
mesoblast limited
Add to My Watchlist
0.93%
!
$1.63

my view is this. the fact that the DMC has confirmed...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.63 |
Change
0.015(0.93%) |
Mkt cap ! $2.082B |
Open | High | Low | Value | Volume |
$1.63 | $1.67 | $1.61 | $6.975M | 4.265M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 707 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 7320 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11200 | 1.625 |
11 | 72699 | 1.620 |
1 | 30000 | 1.615 |
7 | 58298 | 1.610 |
3 | 96589 | 1.605 |
Price($) | Vol. | No. |
---|---|---|
1.635 | 7000 | 1 |
1.640 | 17668 | 3 |
1.645 | 7000 | 1 |
1.650 | 37309 | 4 |
1.655 | 40000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online